TLR4 and inflammatory bowel disease: Interestingly, in humans, polymorphisms in innate immune genes including NOD2 and TLR4 are associated with an increased risk to develop IBD [124] and blockage of TNF-α is currently the most efficacious treatment for IBD in some patients (reviewed in [125]).